Interpace Diagnostics Group, Inc.(IDXG) - 2025 Q4 - Annual Results
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 20, 2026 INTERPACE BIOSCIENCES, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) Delaware 000-24249 22-2919486 (IRS Employer Identification No.) Waterview Plaza, Suite 310, 2001 Route 46 Parsippany, NJ 07 ...